LTR Pharma Limited (ASX:LTP)
Australia · Delayed Price · Currency is AUD 0.5200
+0.0250 (5.05%)
At close: Feb 18, 2026
LTR Pharma Market Cap
LTR Pharma has a market cap or net worth of 94.52 million as of February 18, 2026. Its market cap has decreased by -25.92% in one year.
Market Cap
94.52M
Enterprise Value
62.72M
Revenue
1.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.52
Market Cap Chart
Since December 11, 2023, LTR Pharma's market cap has increased from 52.98M to 94.52M, an increase of 78.42%. That is a compound annual growth rate of 30.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 94.52M | -27.73% |
| Dec 31, 2025 | 130.78M | -10.78% |
| Dec 31, 2024 | 146.59M | 204.77% |
| Dec 29, 2023 | 48.10M | -9.21% |
| Dec 11, 2023 | 52.98M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Paradigm Biopharmaceuticals | 129.58M |
| Island Pharmaceuticals | 107.59M |
| Arovella Therapeutics | 104.85M |
| Cynata Therapeutics | 87.03M |
| Alterity Therapeutics | 87.00M |
| EZZ Life Science Holdings | 80.44M |
| Imugene | 78.77M |
| Radiopharm Theranostics | 77.97M |